--- title: "High-Risk Medical Devices: What’s Changing in 2026 and What It Means for the Industry" description: "The year 2026 brings major shifts in the ecosystem of high-risk medical devices across the European Union. Manufacturers, investors, and CROs must prepare for a much more complex regulatory landscape, shaped by two key developments: the extended MDR transition and the enforcement of the AI Act for high-risk artificial intelligence systems." image: https://tigermedemea.com/hubfs/TIGERMED%20EMEA%20TEAM.jpg --- [![Tigermed](https://tigermedemea.com/hs-fs/hubfs/Master%20logo.png?width=200&name=Master%20logo.png "Tigermed")](https://tigermedemea.com) - [Home](https://tigermedemea.com) - [Solutions](https://tigermedemea.com/solutions) - [Services](https://tigermedemea.com/services) - [Careers](https://tigermedemea.com/careers) - [About](https://tigermedemea.com/about) - [Blog](https://tigermedemea.com/blog) - [Contact](https://tigermedemea.com/contact) December 9, 2025 [Tigermed EMEA](https://tigermedemea.com/blog/author/tigermed-emea) # High-Risk Medical Devices: What’s Changing in 2026 and What It Means for the Industry [#tigermedemea#tigermed](https://tigermedemea.com/blog/tag/tigermedemeatigermed) ![Picture of Tigermed EMEA](https://tigermedemea.com/hubfs/TIGERMED%20EMEA%20TEAM.jpg) ##### Share - - [mailto:?subject=Check%20out%20this%20article%20by%20Tigermed%20EMEA&body=A%20good%20read%20by%20Tigermed%20EMEA%20%0D%0A{url}.](mailto:?subject=Check%20out%20this%20article%20by%20Tigermed%20EMEA&body=A%20good%20read%20by%20Tigermed%20EMEA%20%0D%0A{url}.) The year **2026** brings major shifts in the ecosystem of high-risk medical devices across the European Union. Manufacturers, investors, and CROs must prepare for a much more complex regulatory landscape, shaped by two key developments: the extended MDR transition and the enforcement of the AI Act for high-risk artificial intelligence systems. ### **1. MDR – A critical deadline for certain high-risk devices**   For specific categories (e.g., *custom-made* Class III devices), **26 May 2026** remains an important milestone in the transition to **Regulation (EU) 2017/745 (MDR)**. Manufacturers must finalise their technical documentation, conformity assessment, and post-market surveillance strategy to maintain market access in the EU.   For the medtech sector, 2026 marks a moment of “selection”: only companies with robust regulatory processes will keep their portfolios active. ### **2. The impact of the AI Act – Enforcement for high-risk AI systems**   Starting **2 August 2026**, many medical devices integrating artificial intelligence will fall under the definition of **high-risk AI systems**. This brings additional requirements related to:   - data governance, - transparency and explainability, - continuous monitoring, - algorithmic risk management, - technical documentation aligned with both **MDR** and the **AI Act**.   For smart devices and digital health platforms, **dual compliance** will become the new standard. ### **3. What 2026 means for manufacturers, investors, and CROs**   The industry will undergo a period of reassessment and reinvestment in quality.   - **Manufacturers** will need to strengthen regulatory teams, upgrade quality systems, and prepare for more rigorous audits. - **Investors** will increasingly favour companies with solid compliance strategies. - **CROs**, such as Tigermed EMEA, will play a crucial role in helping companies navigate these new demands. ### **4. How Tigermed EMEA supports medical device manufacturers in 2026**   At Tigermed EMEA, we support medtech innovators through:   - MDR consultancy and documentation preparation, - design & management of clinical studies for high-risk devices, - trials for devices with digital and AI components, - integration of AI Act requirements into research programs, - post-market surveillance and real-world evidence generation.     Our **global expertise** combined with **strong local capability** in Eastern Europe provides a reliable framework for launching or maintaining medical devices on the EU market.     ## ** 2026 is the year when compliance becomes a competitive advantage.**   Tigermed EMEA is the partner that transforms regulatory complexity into real progress. #### ABOUT AUTHOR [Tigermed EMEA](https://tigermedemea.com/blog/author/tigermed-emea) #### SUBMIT YOUR COMMENT Great updates ## Subscribe to our email newsletter today! Lorem ipsum dolor sit amet consectetur adipiscing elit tortor eu egestas [![Tigermed](https://tigermedemea.com/hs-fs/hubfs/Master%20logo.png?width=200&name=Master%20logo.png "Tigermed")](https://tigermedemea.com) Office: [+40 744 100 196](tel:+40744100196) Fax: [+40 256 200 353](tel:+40256200353) 10th Cozia Street 300209 Timișoara, Romania ###### Resources - [About Us](https://tigermedemea.com/about) - [Clinical Trial Services](https://tigermedemea.com/services) - [R&D Solutions](https://tigermedemea.com/solutions) - [Careers](https://tigermedemea.com/careers) - [Company Presentations](https://tigermedemea.com/presentations) ###### Useful Links - Terms and Conditions - Privacy Policy - [Complaints](mailto:complaints@tigermedemea.com) © 2026. All rights reserved ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Tigermed EMEA", "url" : "https://tigermedemea.com/blog/author/tigermed-emea" }, "dateModified" : "2025-12-09T19:35:30.911Z", "datePublished" : "2025-12-09T19:35:30.000Z", "headline" : "High-Risk Medical Devices: What’s Changing in 2026 and What It Means for the Industry", "image" : [ "https://tigermedemea.com/hubfs/TIGERMED%20EMEA%20TEAM.jpg" ], "mainEntityOfPage" : { "@id" : "https://tigermedemea.com/blog/high-risk-medical-devices-whats-changing-in-2026-and-what-it-means-for-the-industry", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://tigermedemea.com/hubfs/Master%20logo.png" }, "name" : "Tigermed SRL" } } ``` ```json { "@context": "http://schema.org", "@type": "Corporation", "mainEntityOfPage":{ "@type":"WebPage", "@id":"https://tigermedemea.com/blog/high-risk-medical-devices-whats-changing-in-2026-and-what-it-means-for-the-industry", "description": "The year 2026 brings major shifts in the ecosystem of high-risk medical devices across the European Union. Manufacturers, investors, and CROs must prepare for a much more complex regulatory landscape, shaped by two key developments: the extended MDR transition and the enforcement of the AI Act for high-risk artificial intelligence systems. " }, "url": "/", "logo": "https://47781279.fs1.hubspotusercontent-na1.net/hubfs/47781279/Master%20logo.png", "image": "", "name": "Tigermed EMEA", "alternateName": "Lagom", "description": "Lorem ipsum dolor sit amet, consectetur adipiscing elit", "address": { "@type": "PostalAddress", "streetAddress": "Cozia 10 ", "addressLocality": "Timisoara", "addressRegion": "Timis", "addressCountry": "Romania", "postalCode": "300209" }, "telephone": "", "email": "", "sameAs": [ "https://www.linkedin.com/company/revivalpixel/", "https://www.linkedin.com/company/revivalpixel/", "https://www.linkedin.com/company/revivalpixel/" ] } ```